InspireMD, Inc. NSPR · Stock Open InspireMD, Inc. in new tab
InspireMD, Inc. Analysis (NSPR)
Is InspireMD, Inc. a good investment? InspireMD, Inc. (NSPR) is currently trading at 0.6196 USD. Market analysts have a consensus price target of 3.33 USD. This suggests a potential upside from current levels.
Earnings Schedule: InspireMD, Inc. is expected to release its next earnings report on Nov. 10, 2026. The market consensus estimate for Forward EPS is -0.48.
Investor FAQ
Does InspireMD, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is InspireMD, Inc.?
InspireMD, Inc. is classified as a Stock. You can compare it against 2 other assets in the "Related Symbols" list on this page.
When is the next earnings date?
The next earnings date is projected to be Nov. 10, 2026. The company currently has a trailing EPS of -0.61.
Company Profile
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.
| Split Date | Split Ratio to 1 |
|---|---|
| April 11, 2011 | 3:1 |
| Dec. 21, 2012 | 1:4 |
| Oct. 1, 2015 | 1:10 |
| Oct. 10, 2016 | 1:25 |
| Feb. 8, 2018 | 0.03 |
| April 1, 2019 | 1:50 |
| April 27, 2021 | 0.07 |
Community Discussion